Novo Nordisk Launches Wegovy Weight-Loss Pill in the U.S.

Novo Nordisk's once-daily Wegovy pill launches in the U.S. at $149/month for self-paying customers, intensifying competition with Eli Lilly in the weight-loss drug market.

Novo Nordisk Launches Wegovy Weight-Loss Pill in the U.S.
Credit: George Frey/Bloomberg
Already have an account? Sign in.